Skip to main content
Clinical Trials/NCT06546878
NCT06546878
Completed
N/A

Cardiac Rehabilitation: Optimisation of the Functional Capacity of Patients Hospitalized With Cardiac Disease

José Manuel Afonso Moreira1 site in 1 country11 target enrollmentMay 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Myocardial Ischemia
Sponsor
José Manuel Afonso Moreira
Enrollment
11
Locations
1
Primary Endpoint
Activity intolerance
Status
Completed
Last Updated
last year

Overview

Brief Summary

The World Health Organization [WHO] (2021) states that Cardiovascular Diseases [CVD] are the leading cause of death in the world, and in 2019 around 17.9 million deaths were caused by CVD and the national picture is no different. In Portugal, demographic ageing continues to be established by the increase in average life expectancy, which in turn leads to an increase in the percentage of the population with CVDs. Of particular note is Ischemic Heart Disease [IHD], which is the second leading cause of death in Portugal In order to prevent and combat the progression of CVD and its complications, Cardiac Rehabilitation [CR] programs have emerged as a secondary prevention method supported by relevant scientific evidence. In this sense, the Portuguese Society of Cardiology recognizes the role of the Rehabilitation Nurse Specialist as a crucial element of CR teams.

Objective: To evaluate the effectiveness of the phase I cardiac rehabilitation program in patients hospitalized with ischemic heart disease, in terms of functional capacity.

Registry
clinicaltrials.gov
Start Date
May 1, 2024
End Date
July 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
José Manuel Afonso Moreira
Responsible Party
Sponsor Investigator
Principal Investigator

José Manuel Afonso Moreira

Clinical Professor

University of Évora

Eligibility Criteria

Inclusion Criteria

  • Patients with Myocardial Ischemia
  • Patients who agree to take part in the rehabilitation exercise program
  • Patients with the cognitive capacity to understand the instructions given, the exercises to be carried out and the teaching provided
  • Patients with clinical and hemodynamic stability
  • Patients participating in the rehabilitation exercise program for at least 2 sessions.

Exclusion Criteria

  • Patients who do not meet the safety criteria for exercising after a cardiac event
  • Patients with osteoarticular pathology that compromises their ability to exercise.

Outcomes

Primary Outcomes

Activity intolerance

Time Frame: The evaluation will be carried out in the first session before starting the rehabilitation program (t0), and in every session during the program for an average of 1 week until the end of the program (t1).

Modified Borg Dyspnea-It makes it possible to assess the subjective perception of effort and determine safe limits when performing exercises. Esta avaliação permite aos participantes avaliarem-se numa escala de 0 a 10, em que quanto mais baixa for a pontuação, menor será o nível de fadiga.

Secondary Outcomes

  • Health-related quality of life(The evaluation will be carried out in the first session before starting the rehabilitation program (t0). The second evaluation after finishing the program (t1), on average 1 week.)
  • Distance(The first evaluation is carried out in the first session before starting the rehabilitation program (t0), and in all the sessions during the program, on average 1 week before the end of the program (t1).)

Study Sites (1)

Loading locations...

Similar Trials